Clinical Trial Update: Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating the safety, tolerability, and antiretroviral activity of dasatinib in adults with recent HIV-1 infection. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: Eva Bonfill | Conditions: Recent HIV-1 Infection | Phase 2 | Status: RECRUITING